Explore more publications!

Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on November 13, 2025

Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability
Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights
Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update
Konica Minolta Healthcare Partners with Leading Teleradiology Provider, Implements Exa Teleradiology Powered by NewVue
PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq
Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year
IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update
Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results
Cylinder Health strengthens gut-brain leadership with new Head of Gut-Brain Health and Clinical Advisory Board appointment
Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer’s Disease
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq
Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Opus Genetics Announces Dosing of First Participant in OPGx-BEST1 Phase 1/2 Gene Therapy Clinical Trial for Best Disease
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions